Menopausal hormone therapy and breast cancer risk: a population-based cohort study of 1.3 million women in Norway.

Nathalie C Støer Siri VangenDeependra SinghRenée Turzanski Fortner Solveig HofvindGiske UrsinEdoardo Botteri

Published in: British journal of cancer (2024)

The use of oral and transdermal HT was associated with an increased risk of BC. The associations varied according to HT type, individual drugs, molecular subtype, detection mode and BMI.

Keyphrases

breast cancer risk
body mass index
loop mediated isothermal amplification
label free
real time pcr
weight gain
single molecule
stem cells
metabolic syndrome
bone marrow
cell therapy